Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

A new survey of 500 UK adults, conducted by LloydsPharmacy Online Doctor, found that only 25% of people would know the common ...

Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, ...

USA: Researchers have found in a new study that even in the absence of anemia, iron deficiency (ID) during adolescence is ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

Sickle cell disease refers to a group of inherited blood disorders with symptoms like anaemia and blocked blood vessels. About 80% of the world's sickle cell disease cases occur in sub-Saharan Africa.

Panelists discuss how to select among the four available JAK inhibitors (Ruxolitinib, Fedratinib, Pacritinib, and Momelotinib) based on patient-specific factors such as anemia, thrombocytopenia, and ...

Personalized drug treatments have outperformed chemotherapy for leukemia patients in a trial led by Leeds researchers. Newly ...

Experts share insights on restless legs syndrome, from its neurological roots to treatment options that can improve sleep and ...

Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.